首页> 外文OA文献 >Oxidation of anticancer Pt(ii) complexes with monodentate phosphane ligands: Towards stable but active Pt(iv) prodrugs
【2h】

Oxidation of anticancer Pt(ii) complexes with monodentate phosphane ligands: Towards stable but active Pt(iv) prodrugs

机译:具有单齿膦配体的抗癌Pt(ii)复合物的氧化:形成稳定但有活性的Pt(iv)前药

摘要

The synthesis, characterization and cytotoxicity studies of two novel platinum(iv) complexes, trans-PtCl4(dma)(PPh3), 1, and trans-PtCl4(ipa)(PPh3), 2, where dma is dimethylamine and ipa is isopropylamine, have been carried out. Both complexes contain aliphatic amines trans to phosphane ligands as a good alternative to take advantage of the phosphane group lipophilicity and the stability of platinum(iv) to obtain more effective drugs. Moreover, the complexes are stable in solution and such stability allowed their antitumoral action and DNA interaction to be checked and proved. © 2013 The Royal Society of Chemistry.
机译:两种新颖的铂(iv)配合物,反式-PtCl4(dma)(PPh3),1和反式-PtCl4(ipa)(PPh3),2的合成,表征和细胞毒性研究,其中dma是二甲胺,ipa是异丙胺,已经进行了。两种配合物都含有反式为膦配体的脂肪胺,这是利用膦基的亲脂性和铂(iv)的稳定性来获得更有效药物的良好选择。此外,该复合物在溶液中是稳定的,并且这种稳定性允许检查和证明它们的抗肿瘤作用和DNA相互作用。 ©2013皇家化学学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号